Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
will keep the position open. In that case, we are looking forward to your application after the above-mentioned deadline. Where to apply Website https://academicpositions.com/ad/empa/2026/postdoctoral
-
forging connections all over the world, we work together to develop solutions for the global challenges of today and tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026
-
: https://www.epfl.ch/labs/hobel/ For more information about Prof. Dusan Licina: https://people.epfl.ch/dusan.licina For more information about EPFL: https://www.epfl.ch/en/ For more information about Smart
-
portal. Applications by e-mail and by post will not be considered. Where to apply Website https://academicpositions.com/ad/empa/2026/postdoc-position-on-redox-targeted-f… Requirements Research
-
Foster ([email protected]) - https://laser.epfl.ch/ Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable Reference: 2464
-
, cell biology and gas-exchange physiology. Within the research unit “Cereal Stem Cell Systems - RU52350; https://cerealstemcells.de ”, we are recruiting a Postdoc to investigate how grass leaves spatially
-
, diabetes and cancer; see https://data.snf.ch/grants/grant/189065 ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in ML-Based Co-Design at EPFL Mission The EPFL computer vision lab (https://www.epfl.ch
-
positions. https://www.epfl.ch/labs/entc/ Education You will work closely with Dr. Davide Bavato, head of EPFL’s recently established Entrepreneurship Education Hub. The Hub is developing a structured
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs